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Abstract
Background: Donated human milk (DHM) is a safe alternative in the absence of mother’s own milk (MOM);
however, specific clinical indications for DHM use and its impact on subsequent feeding practice remain unclear.
We aimed to audit local DHM use and explore the impact of the introduction of DHM as the first enteral feed on
subsequent MOM availability.
Methods: We retrospectively audited DHM recipients nursed in Royal Hospital for Children, Glasgow from 2014 to
2016 against local guidelines. Data were collected from an operational electronic database. Descriptive data analysis
was performed to describe DHM use. To explore the association between the first human milk feed with subsequent
MOM availability Kruskal Wallis test was used. Adjustments for confounding variables were performed using analysis of
variance (ANOVA).
Results: A total of 165 recipients of DHM (5.3% of all admission to RHC) were identified. The majority of recipients
(69%) were born < 32 weeks of gestation. The main indication for DHM was prematurity, other indications included
congenital anomalies of bowel and heart. The local guideline was adhered to in 87% of cases. The median interquartile
range (IQR) at DHM introduction was 6 days (3, 17) and the duration of use was 12 days (6, 22). In those born < 32
weeks of gestation the type of human milk (DHM and/ or MOM) used as first feed did not influence the subsequent
median IQR days of feeding with any MOM [DHM 40 (9, 51); MOM 28 (17, 49), MOM & DHM 17 (10, 26) p value = 0.465]
after adjusting for birthweight and length of hospital stay.
Conclusions: In our unit, DHM is mainly used in preterm neonates in accordance with existing local guidance. Using
DHM as first milk feed did not affect subsequent MOM availability.
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Background
Mother’s own milk (MOM) is the optimal feed for all
newborn babies, especially the sickest and most vulner-
able. When insufficient MOM is available donated human
milk (DHM) is recommended as an alternative [1–3].
DHM differs from MOM for a variety of reasons, many of
which relate to the handling and processing of the milk.
The nutritional content of DHM varies greatly, with a
mean difference in energy intake of 38.7 kcal/kg/day based
on full enteral feeds of 180ml/kg/day [4, 5]. In addition,
freezing, storage and heat treatment all impact on milk
components and qualities. The Holder pasteurisation
method (heating milk for 30min at 62.5 C) can reduce
both fatty and amino acid content in DHM. For example,
in one study the fatty acid content of DHM was 22% lower
after pasteurisation [6]. Another study found the mean
difference of valine (an amino acid) content in pasteurised
DHM was lower by 22mmol compared to EBM from
healthy women [7]. Bioactive proteins such as immuno-
globulins which are anti-inflammatory and important for
immune modulation are lower in DHM than MOM be-
cause of pasteurisation [8]. Despite these differences,
DHM has been demonstrated to retain some of the bene-
fits of MOM, in particular, a reduction in the incidence of
necrotising enterocolitis (NEC). A recent Cochrane meta-
analysis of nine clinical trials (1017 preterm infants)
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showed that, compared with formula feeding, DHM was
significantly associated with a lower risk of NEC [9, 10].
Given that approximately 50% of NEC cases require sur-
gery or die [11], and that survivors are at risk of sequelae
including; prolonged dependence on parental nutrition,
short bowel syndrome and impaired neurodevelopment
[12, 13], any intervention that reduces the risk of NEC is
clinically and economically important. It is however well
recognised that further research is required to inform
practice and assist in prioritising DHM distribution [14].
A frequently cited concern associated with DHM use
is a potential negative impact on the provision of MOM.
A recent systematic review provided reassurance that
breastfeeding rates are not adversely affected by the use
of DHM, however, it highlighted the limited evidence
base from which it drew its conclusions [15]. In particu-
lar, it is unclear whether using DHM as the first enteral
feed will adversely influence subsequent MOM supply.
In the United Kingdom there are operational guide-
lines for milk banks but no national guidance on clinical
indications for DHM usage [16]. In the absence of evi-
dence based, cost effective eligibility criteria, local guide-
lines are often used to inform practice. The primary aim
of this work was to audit the use of DHM in our neo-
natal unit, comparing it to local guidance. The secondary
aim was to explore the impact of using DHM as the first
milk on subsequent feeding practice.
Methods
Setting
The Scotland wide milk banking service, hosted by
Greater Glasgow and Clyde Health Board, was officially
launched in 2013 to provide DHM equitably across the
country. Donated milk is processed and stored in Glasgow
prior to transfer for use in neonatal units within the 14
Scottish health boards. The neonatal unit in the Royal
Hospital for Children (RHC), Glasgow provides local peri-
natal care, regional neonatal surgical services and national
neonatal cardiac and extracorporeal life support services.
Due to the nature of these services, babies from across
Scotland may be transferred into the RHC for specialist
care at some point during their postnatal course.
Data
Using the milk bank database all infants who received
DHM over a three year period following the expansion
of the milk banking service (January 2014 to December
2016) were identified. We retrospectively audited all
recipients who were nursed in the RHC, Glasgow at any
point during their postnatal stay (inborn and transferred
in postnatally for specialist care). Caldicott Guardian
approval, which is required for research involving patient
data collection, was obtained.
Data were collected from an electronic medical record
platform (Badger.net). Data collected included demo-
graphic characteristics (gestational age, birthweight and
length of hospital stay), feeding history (age at initiation
and type of first milk feed, age at initiation and indica-
tion for starting DHM, duration of feeding with DHM
solely or mixed with other milk). We audited this against
Greater Glasgow and Clyde local guidelines for DHM
use which are; prematurity born < 32 weeks of gesta-
tional age, refeeding post NEC and congenital anomalies
of the bowel and heart. The time of discontinuing DHM
was based on clinical decision. NHS Greater Glasgow
and Clyde local guidelines for DHM feeding are available
in the Additional file 1.
Analysis
Descriptive data analysis was performed using Microsoft
Excel and IBM SPSS Statistics Data Editor, version 21.
Tests included frequencies, median and interquartile
range (IQR) as data were nonparametric. Comparison of
all DHM users’ characteristics, feeding and length of stay
was done using Kruskal Wallis test. Subgroup analysis
for infants born < 32 weeks of gestation was performed
also using the Kruskal Wallis test to explore the associ-
ation between the first human milk feed with subsequent
MOM availability (i.e. feeding with any MOM on its
own or with other milk expressed in days of feeding and
proportion of feeding days over the admission). Two ba-
bies born < 32 weeks of gestation who received formula
for their first feed were excluded from this analysis. If
the overall Kruskal Wallis test was significantly different
(< 0.05), a post hoc test was done using pairwise com-
parison of independent samples (Kruskal Wallis 1-way
ANOVA (K samples) to determine groups that differed
from each other. Adjustments for confounding variables
(birthweight and length of hospital stay) were performed
using analysis of variance (ANOVA).
Results
We identified 279 recipients of DHM across Scotland
over the audit period; 88 in 2014 increasing to 108 in
2016. Of these, 165 (56%) were managed at some point
in the RHC, Glasgow. This cohort represented 5.3% of
all admissions to the RHC neonatal unit over the three-
year audit period.
The majority of DHM recipients were preterm, 114 of
whom were born < 32 weeks of gestation and 30 between
32 and 36+ 6 days weeks of gestation. The remainder (21)
were term babies who received DHM mainly because
they had a congenital anomaly (Table 1). Other indica-
tions for using DHM for the group as a whole included
congenital bowel disease (7%), congenital heart disease
(7%), and refeeding following NEC (2%). Twenty-one in-
fants (13%) received DHM differing from existing
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guidelines. The majority of babies (76%) received DHM
to supplement MOM.
The median (IQR) age at initiation of feeds for the
group as a whole was three days (2, 4). The age at initi-
ation in differing gestational age groups is shown in
Table 1. Two-thirds of those born < 32 weeks of
gestation received MOM as their first feed compared to
a third of term babies. Only two babies born < 32 weeks
of gestation received formula rather than human milk
(MOM or donated) as their first feed. The highest
proportion fed DHM as first milk was in term infants
(Fig. 1).
Table 1 Characteristics and feeding pattern of DHM recipients (N = 165)
Very Preterm
< 32 weeks
Late preterm
32–36+ 6 weeks
Term
≥ 37 weeks
p values
Number of babies (%) 114 (69%) 30 (18%) 21 (13%)
Gestational age (weeks) 28 (26, 30)a ,b 33 (32, 35)a 38 (37, 39)b < 0.001
Birthweight (grams) 1040 (835, 1246)a, b 1893 (1459, 2195)a 2910 (2410, 3442)b < 0.001
Feeding initiation age (days) 3 (2, 4) 2 (2, 4) 5 (2, 10) 0.916
DHM feeding
Initiation age (days) 7 (3, 19) 5 (3, 8) 5 (4, 14) 0.211
Any DHM duration (days) 14 (6, 25)a 10 (5, 14)a 9 (4, 15) 0.001
Length of stay (days) 66 (54, 108)a, b 28 (21, 50)a 28 (9, 65)b < 0.001
DHM indication (number)
Prematurity 114 23
Congenital heart disease 1 4 6
Congenital bowel anomaly 2 9
Other 1 1 6
Data presented as median (interquartile range), MOM mother’s own milk, DHM donated human milk, Length of stay represent infants’ hospital admission
including their stay in the Royal Hospital for Children, p value was calculated based on Kruskal Wallis test, Post hoc analysis was done using pairwise comparison
of independent samples, Kruskal Wallis 1-way ANOVA (K samples). Superscripts are significantly different for comparisons between groups (avery preterm versus
late preterm, bvery preterm versus term, clate preterm versus term)
Fig. 1 Proportion of babies according to the type of first milk of feeding in donated human milk recipients (n = 165). Footnotes: MOM: mother’s
own milk, DHM: donated human milk
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The median (IQR) age at introduction of DHM for the
group as a whole was six days (3, 17), and the median
duration of use was 12 days (6, 22). The age at introduc-
tion and duration of DHM use in differing gestational
age groups is shown in Table 1. Those born < 32 weeks
of gestation received DHM for longer than the more
mature groups (Table 1).
Subsequent milk feeding in babies born < 32 weeks of
gestation who received human milk (MOM and/or
DHM) as their first feed is described in Fig. 2. There was
no significant difference in the number of days of feed-
ing with any MOM (after correction for birthweight and
length of hospital stay) and proportion of any MOM in-
take over the admission period based on the first milk of
feeding (Table 2).
Discussion
Our data provide reassurance that DHM use in RHC
adheres to the current guidance in the majority of cases.
The commonest deviation from this guidance is in the
late preterm group (32–36+ 6 weeks). This may be due to
the lack of a clear evidence base to guide clinical use
[3, 17], it may also reflect therapeutic creep or
parental request as awareness of, and access to DHM
increases [18, 19]. It is encouraging to see that the ma-
jority of babies (76%) received DHM as a supplement to,
rather than in place of MOM and this replicates the find-
ing of others throughout the United Kingdom [20, 21] and
the United States [18]. The median age at initiation of en-
teral feeds for the group as a whole was three days, in part
reflecting the time it can take to establish lactation follow-
ing the delivery of a preterm and/or sick baby.
Access to DHM has been associated with positive in-
hospital feeding outcomes, such as earlier initiation of
feeds, faster feed advancement and increased volumes of
MOM [22, 23] but equally early (< 48 h) introduction of
DHM has been linked to reduced MOM availability [24].
In our population of babies born < 32 weeks of gestation
the type of first human milk (MOM or donated) did not
appear to have a negative impact on subsequent MOM
availability. This raises the possibility of introducing
enteral feeds of DHM at an earlier stage with a view to
expediting the time to establish full milk feeds and mini-
mising the duration (and risks) of central venous access
and parenteral nutrition [25]. Ideally, any such change in
practice should be subject to randomised evaluation or
Fig. 2 Feeding pattern over admission in infants born < 32 weeks of gestation (n = 112). Footnotes: Box plots represent the median (interquartile
range) of feeding pattern over admission expressed as percentage of days over hospital stay. MOM: mother’s own milk, DHM: donated
human milk
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at the very least quality improvement methodology to
ensure that it did not adversely impact maternal milk
provision or mitigate the benefits of early colostrum
administration.
In our sample, over 60% of babies born < 32 weeks of
gestation received MOM as first feed compared to only
a third of term babies (the majority of whom had con-
genital anomalies of either bowel or heart, and around
half of whom did not have any MOM during their hos-
pital stay). The two groups are obviously very different,
but this difference in access to MOM may reflect the
emphasis placed on supporting early milk expression for
the preterm population. It is important to remember
that MOM confers many benefits at any gestation age,
especially in those vulnerable infants requiring admis-
sion to a neonatal unit. DHM use in term infants ap-
pears to be increasing. A recent American study
described the use of DHM in healthy term infants to re-
duce exposure to formula milk whilst lactation was
established. They reported higher exclusive breastfeeding
at discharge [26]. However, a recent randomised clinical
trial found early DHM supplementation in term infants
did not significantly increase breastfeeding at the age
of one week or three months [27]. Although DHM
feeding in term newborns may reduce formula expos-
ure, the effect on breastfeeding duration and formula
exposure needs further investigation. Given the public
health implications of improved societal breastfeeding
rates the potential role of DHM in this situation is
worthy of further study. The Scottish Government
has recently funded a quality improvement initiative
whereby DHM will be used to support breastfeeding
mothers on the postnatal wards if the baby requires a
supplementary feed. The primary aim is to facilitate
the establishment and maintenance of breastfeeding
by avoiding the negative impact of early formula
feeding [28].
Conclusion
Whilst uncertainty around the optimal clinical indications
for DHM remain, it is important that its use is monitored.
Our data suggested that in Scotland adherence to current
recommendations is good and that judicious DHM use in
the preterm population is not negatively impacting mater-
nal milk availability. However, it is clear that further study
is required to fully delineate the role of DHM in contem-
porary neonatal care.
Additional file
Additional file 1: Criteria for who should be offered donated human
milk (based on NHS Greater Glasgow and Clyde guidelines). (DOC 23 kb)
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